Loading market data...
Latest Top News
Sun Pharma Launches Affordable Semaglutide Therapy Under Noveltreat And Sematrinity Brands
Sun Pharma has officially launched semaglutide injections in India under the brand names Noveltreat and Sematrinity. Noveltreat is priced between ₹900–₹2,000 per weekly dose for chronic weight management, while Sematrinity costs ₹750–₹1,300 weekly for type 2 diabetes. Both products feature advanced prefilled pen delivery systems.
Stay Ahead – Explore Now! Key Stocks to Watch on June 10: Ajanta Pharma, Bharti Airtel, IndiGo, NLC India






